Colin Miller

Contributing Writer

5 Years of Experience

About

Colin Miller is a staff writer and medtech analyst. Colin focuses on emerging and disruptive medical device technologies within vast therapeutic areas such as women’s health, wound care, neurovascular, critical care, surgical robotics and cardiovascular. Colin attended McGill University in Montreal and graduated from the University of Minnesota.

Articles from Colin Miller:

Emerging Markets

The Digest: May 2026

In this month's news, clearances for imaging technologies in cardiovascular, orthopedics, and neurosurgery; device partnerships with pharma and genetics; Roche buys PathAI for $1 billion, and more.

Read Article